technetium tc 99m hydroxymethylene diphosphonate has been researched along with Graft vs Host Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Marini, P; Fornecker, LM; Laplace, A; Matuszak, J; Namer, IJ | 1 |
| Gremmels, JM; Kirk, GA | 1 |
2 other study(ies) available for technetium tc 99m hydroxymethylene diphosphonate and Graft vs Host Disease
| Article | Year |
|---|---|
Spleen Uptake on Bone Scan After Frequent Platelet and RBC Transfusions.
Topics: Bone and Bones; Erythrocyte Transfusion; Fluorodeoxyglucose F18; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Platelet Transfusion; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Spleen; Technetium Tc 99m Medronate; Young Adult | 2016 |
Two patients with abnormal skeletal muscle uptake of Tc-99m hydroxymethylene diphosphonate following liver transplant: nephrogenic fibrosing dermopathy and graft vs host disease.
Topics: Fibrosis; Graft vs Host Disease; Humans; Kidney Diseases; Liver Transplantation; Male; Middle Aged; Muscle, Skeletal; Radionuclide Imaging; Radiopharmaceuticals; Skin Diseases; Technetium Tc 99m Medronate | 2004 |